Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.77 |
| ▸ | CA12 | O43570 | 3/20 | 0.63 |
| ▸ | CA1 | P00915 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 3/20 | 0.63 |
| ▸ | CA7 | P43166 | 3/20 | 0.63 |
| ▸ | CA9 | Q16790 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | IKBKB | O14920 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31680794 | 0.93 | HRH3 (0.78) | HRH3KCNH2CA12CA1CA2 | |
| SCHEMBL14058968 | 0.86 | HRH3 (0.67) | HRH3KCNH2CA12CA1CA2 | |
| SCHEMBL32689494 | 0.84 | HRH3 (0.77) | HRH3KCNH2CA12CA1CA2 | |
| SCHEMBL7466649 | 0.81 | HRH3 (1.00) | HRH3KCNH2CA12CA1CA2 | |
| SCHEMBL76269 | 0.80 | RAB9A (0.66) | HRH3KCNH2RAB9ANPC1USP2 | |
| SCHEMBL25494117 | 0.80 | HRH3 (0.65) | HRH3KCNH2CA12CA1CA2 | |
| SCHEMBL8360712 | 0.79 | RAB9A (0.68) | HRH3KCNH2RAB9ANPC1USP2 | |
| SCHEMBL16301445 | 0.77 | RAB9A (0.66) | HRH3KCNH2RAB9ANPC1USP2 | |
| SCHEMBL10817906 | 0.77 | RAB9A (0.76) | HRH3TSHRRAB9ANPC1USP2 | |
| SCHEMBL7945866 | 0.77 | RAB9A (0.66) | HRH3KCNH2RAB9ANPC1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583818-B2 | Compound, preparation method thereof, and use thereof | DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (KR) | 2026-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583818-B2 | Compound, preparation method thereof, and use thereof | TYRO3, TH, SRMS | HRH3 201/4885KCNH2 4556/4885CA12 2090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.